Apellis Pharmaceuticals Inc (APLS)
42.88
+0.90
(+2.13%)
USD |
NASDAQ |
May 13, 11:34
Apellis Pharmaceuticals Price: 42.88 for May 13, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 10, 2024 | 42.86 | 43.06 | 41.35 | 41.99 | 979511.0 |
May 09, 2024 | 42.73 | 43.00 | 41.71 | 42.52 | 1.061M |
May 08, 2024 | 44.12 | 44.12 | 41.57 | 42.30 | 2.160M |
May 07, 2024 | 45.10 | 47.60 | 41.75 | 43.90 | 4.519M |
May 06, 2024 | 47.32 | 49.06 | 47.18 | 48.81 | 1.850M |
May 03, 2024 | 48.46 | 48.76 | 47.22 | 47.46 | 1.107M |
May 02, 2024 | 46.62 | 47.74 | 46.10 | 47.49 | 1.021M |
May 01, 2024 | 44.75 | 47.23 | 44.49 | 46.05 | 2.334M |
Apr 30, 2024 | 46.60 | 46.85 | 38.22 | 44.19 | 6.668M |
Apr 29, 2024 | 48.98 | 49.38 | 47.56 | 47.84 | 1.401M |
Apr 26, 2024 | 50.00 | 50.98 | 48.85 | 49.86 | 1.215M |
Apr 25, 2024 | 49.27 | 49.31 | 47.02 | 47.93 | 1.122M |
Apr 24, 2024 | 48.84 | 50.40 | 48.62 | 49.93 | 1.246M |
Apr 23, 2024 | 48.18 | 50.00 | 47.97 | 48.72 | 1.185M |
Apr 22, 2024 | 48.08 | 48.42 | 46.63 | 47.64 | 784535.0 |
Apr 19, 2024 | 47.52 | 48.19 | 46.53 | 47.53 | 1.179M |
Apr 18, 2024 | 47.91 | 48.83 | 46.40 | 47.51 | 1.946M |
Apr 17, 2024 | 51.67 | 52.44 | 47.96 | 48.03 | 1.679M |
Apr 16, 2024 | 51.40 | 53.06 | 50.70 | 51.82 | 1.008M |
Apr 15, 2024 | 51.76 | 53.04 | 50.28 | 51.50 | 2.616M |
Apr 12, 2024 | 55.13 | 55.60 | 50.07 | 51.79 | 2.003M |
Apr 11, 2024 | 57.15 | 57.85 | 55.22 | 55.73 | 1.054M |
Apr 10, 2024 | 53.71 | 57.03 | 53.71 | 56.84 | 780445.0 |
Apr 09, 2024 | 53.77 | 55.33 | 53.45 | 55.12 | 852427.0 |
Apr 08, 2024 | 55.99 | 55.99 | 53.76 | 53.81 | 809179.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
17.91
Minimum
Mar 17 2020
93.31
Maximum
Jun 13 2023
46.32
Average
45.16
Median
Price Benchmarks
Blueprint Medicines Corp | 106.55 |
Sarepta Therapeutics Inc | 129.94 |
Inspire Medical Systems Inc | 162.24 |
Alnylam Pharmaceuticals Inc | 150.49 |
Biomarin Pharmaceutical Inc | 81.04 |
Price Related Metrics
PS Ratio | 9.897 |
Price to Book Value | 19.52 |
Earnings Yield | -8.07% |
Market Cap | 5.205B |